Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06032000
What this trial is testing

Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

Who this might be right for
COVID-19 InfectionCOVID-19 Vaccine Adverse Reaction
Lemonex 20
Not applicableNo Longer AvailableNCT04802083
What this trial is testing

COVID-19 Soliris Expanded Access Protocol

Who this might be right for
Covid19
Alexion Pharmaceuticals, Inc.
Not applicableWithdrawnNCT04473183
What this trial is testing

Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota

Who this might be right for
Covid19SARS-CoV InfectionSARS-CoV-2+1 more
University of Minnesota
Large-scale testing (Phase 3)Study completedNCT04613271
What this trial is testing

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia

Who this might be right for
Infectious DiseaseSARS-CoV InfectionCovid19
Ina-Respond 130
Large-scale testing (Phase 3)UnknownNCT04808895
What this trial is testing

Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19

Who this might be right for
COVID-19Thrombosis Pulmonary
Azienda Ospedaliera Universitaria Integrata Verona 204
Large-scale testing (Phase 3)Study completedNCT04447469
What this trial is testing

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Who this might be right for
COVID
Kiniksa Pharmaceuticals International, plc 814
Not applicableStudy completedNCT04570254
What this trial is testing

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19

Who this might be right for
Pneumonia, ViralCovid19ARDS+1 more
Unidad Temporal COVID-19 en Centro Citibanamex 110
Testing effectiveness (Phase 2)Study completedNCT05077254
What this trial is testing

COVID Protection After Transplant-Immunosuppression Reduction

Who this might be right for
Kidney Transplant RecipientsLiver Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT04392973
What this trial is testing

FAvipiravir and HydroxyChloroquine Combination Therapy

Who this might be right for
COVID19
King Abdullah International Medical Research Center 268
Large-scale testing (Phase 3)Study completedNCT07222384
What this trial is testing

Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

Who this might be right for
COVID-19SARS-COV-2 Infection
BioNTech SE 344
Large-scale testing (Phase 3)Ended earlyNCT04403685
What this trial is testing

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers

Who this might be right for
COVIDSARS PneumoniaCytokine Release Syndrome
Beneficência Portuguesa de São Paulo 129
Early research (Phase 1)WithdrawnNCT05630352
What this trial is testing

Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children

Who this might be right for
COVID-19
BioNTech SE
Testing effectiveness (Phase 2)Study completedNCT04349098
What this trial is testing

Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection

Who this might be right for
Coronavirus Infection
Karyopharm Therapeutics Inc 190
Not applicableUnknownNCT04637906
What this trial is testing

Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2)

Who this might be right for
Covid19
University of Campania Luigi Vanvitelli 290
Testing effectiveness (Phase 2)Study completedNCT04888949
What this trial is testing

ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

Who this might be right for
SARS-CoV-2 Infection( COVID-19 )
Rohto Pharmaceutical Co., Ltd. 15
Not applicableStudy completedNCT05067400
What this trial is testing

SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort

Who this might be right for
HIV-1-infectionSARS-CoV InfectionCovid19
Royal Free Hospital NHS Foundation Trust 615
Not applicableEnded earlyNCT04648709
What this trial is testing

Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19

Who this might be right for
Covid19
Centre Hospitalier Universitaire de Saint Etienne 73
Not applicableStudy completedNCT04542954
What this trial is testing

Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East

Who this might be right for
Covid19Kidney Transplant InfectionRisk Factor, Cardiovascular+3 more
Hamid Al-Essa Organ Transplant Center 104
Not applicableUnknownNCT05197686
What this trial is testing

Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.

Who this might be right for
Corona Virus InfectionARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2Oxygen Deficiency
Pomeranian Medical University Szczecin 100
Not applicableStudy completedNCT04766983
What this trial is testing

Incidence of VAP in Patients With Severe COVID-19

Who this might be right for
Ventilator Associated PneumoniaCovid19
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 323
Next Page